Potential sources sought to participate in the regional standardization of Asthma Protocol Supplies. TRICARE Pacific Region 12, a military integrated delivery network (IDN), comprised of Army, Navy, Air Force, Marine Corps and Coast Guard medical tre atment facilities in Hawaii, Japan, Okinawa, Korea and Guam are in the process of standardizing Asthma Protocol Supplies. This product line includes pediatric valved holding chambers for aerosol delivery of medication, aerosol nebulizers, and peak flow met ers. If your company currently holds or in the process of obtaining a Distribution and Pricing Agreement (DAPA) with the Defense Supply Center-Philadelphia (DSCP) Asthma Protocol Supplies, your company is eligible to participate in the standardization proc ess. Please respond by Email: [email protected] and provide your company name, address, point of contact, telephone, fax and E-mail address and answers to the below listed questions no later than April 6, 2004 1. Are your products available through the prime vendor Owens Minor or Cardinal? If yes, what is your DAPA number? 2. Under what brand(s) does your company manufacture or distribute your product? 3. Are your products latex free? 4. Under what standards are your products manufactured? 5. Are your products FDA approved? 6. That types of educational tools or materials do you have for this product line? 7. What kind of staff training does your company provide? 8. Does your company provide customer service 24/7? 9. Is there any history of backorders and/or recalls for this product group? If yes, please answer: a. Dates and duration, b. Cause, c. Resolution. Peak Flow Meter: (1) Does your company manufacture a peak flow meter? (2) Do your peak flow meters meet the most current American Thoracic Society Standards for Spirometry adopted in 1994 and the educational guidelines recommended by the National Asthma E ducation Prevention Program (NAEPP) of the National Institutes of Health? Aerosol Nebulizer: (1) Does your company manufacture a nebulizer that can be operated in both a continuous mode and/or breath-activated mode? If so, can this product be changed from mode to mode? (2) Has your product been published, peer reviewed, bench and/or clinically studied? If so, please list? Pediatric Valved Holding Chamber: (1) Does your company manufacture a line of pediatric valved holding chambers for all children aged bi rth to 17 years old? (2) Does your product meet CSA standards for drop testing? (3) Has your product been tested using USP methods normalizing the dose for the following pMDI formulations? a. Flovent 110 µg CFC and HFA formulations, b. Albuterol 90 µ g CFC and HFA formulations, c. Ipratropium Bromide 18 µg, d. Albuterol/ipratropium bromide combination (CombiVentO), (4) Are instructions for use of this product consistent with recommendations for Holding Chambers according to the AARC Clinical Practic e Guideline: Selection of an Aerosol Delivery Device for Neonatal and Pediatric Patients as published in Respiratory Care 1995; 40(12):1325-1335? Please FEDEX/UPS your product literature on Asthma Protocol Supplies by April 6, 2004 to: Ms. Cheryl A. Janus, RN, MBA, Tricare Pacific Lead Agency, 1 Jarrett White Road, MCHK-LA, Tripler, HI 96859-5000, Telephone: (808) 433-7985

Bid Protests Not Available